NCT06550648View on ClinicalTrials.gov

Evaluation of the Role of Epstein-Bar Virus in Patients With Pulmonary Arterial Hypertension

CompletedOBSERVATIONAL
Enrollment

78

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

March 30, 2024

Study Completion Date

April 1, 2024

Conditions
Pulmonary Arterial Hypertension
Interventions
PROCEDURE

Right Heart Catheterization (Swan Ganz Catheter)

Swan Ganz Catheter only for PAH patients, Using the swan ganz and pressure transducer

Trial Locations (1)

11562

Cairo University- Faculty Of Medicine, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT06550648 - Evaluation of the Role of Epstein-Bar Virus in Patients With Pulmonary Arterial Hypertension | Biotech Hunter | Biotech Hunter